APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Rabies Immunoglobulin (ERIG)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Equine Rabies Immunoglobulin (ERIG) Market Analysis and Forecast 2026-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchEquine Rabies Immunoglobulin (ERIG) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Rabies Immunoglobulin (ERIG) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Equine Rabies Immunoglobulin (ERIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Rabies Immunoglobulin (ERIG) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Rabies Immunoglobulin (ERIG) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Equine Rabies Immunoglobulin (ERIG) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Equine Rabies Immunoglobulin (ERIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Equine Rabies Immunoglobulin (ERIG) include Wuhan Institute of Biological Products, Serum China, Lanzhou Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Equine Rabies Immunoglobulin (ERIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Equine Rabies Immunoglobulin (ERIG), also provides the sales of main regions and countries. Of the upcoming market potential for Equine Rabies Immunoglobulin (ERIG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Equine Rabies Immunoglobulin (ERIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Equine Rabies Immunoglobulin (ERIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Equine Rabies Immunoglobulin (ERIG) sales, projected growth trends, production technology, application and end-user industry.

Equine Rabies Immunoglobulin (ERIG) Segment by Company

Wuhan Institute of Biological Products

Serum China

Lanzhou Institute of Biological Products

Premium Serums

Haffkine Bio-Pharmaceutical

Bharat Serums

Equine Rabies Immunoglobulin (ERIG) Segment by Type

1500IU

1000IU

400IU

Other

Equine Rabies Immunoglobulin (ERIG) Segment by Application

Category II Exposure

Category III Exposure

Equine Rabies Immunoglobulin (ERIG) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Rabies Immunoglobulin (ERIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Rabies Immunoglobulin (ERIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Rabies Immunoglobulin (ERIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Equine Rabies Immunoglobulin (ERIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Rabies Immunoglobulin (ERIG) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1500IU Major Manufacturers Table 3. 1000IU Major Manufacturers Table 4. 400IU Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Category II Exposure Major Manufacturers Table 8. Category III Exposure Major Manufacturers Table 9. Equine Rabies Immunoglobulin (ERIG) Industry Trends Table 10. Equine Rabies Immunoglobulin (ERIG) Industry Drivers Table 11. Equine Rabies Immunoglobulin (ERIG) Industry Opportunities and Challenges Table 12. Equine Rabies Immunoglobulin (ERIG) Industry Restraints Table 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2021-2026) Table 17. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2027-2032) Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2021-2026) & (K Tons) Table 20. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2027-2032) & (K Tons) Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2021-2026) Table 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2027-2032) Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Equine Rabies Immunoglobulin (ERIG) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Equine Rabies Immunoglobulin (ERIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Equine Rabies Immunoglobulin (ERIG) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers, Product Type & Application Table 31. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Equine Rabies Immunoglobulin (ERIG) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2021-2026) Table 38. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2027-2032) Table 39. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 40. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 41. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 42. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2021-2026) Table 43. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2027-2032) Table 44. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2026) & (US$/Ton) Table 45. Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2027-2032) & (US$/Ton) Table 46. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2021-2026) Table 50. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2027-2032) Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 53. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 54. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2021-2026) Table 55. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2027-2032) Table 56. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2026) & (US$/Ton) Table 57. Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2027-2032) & (US$/Ton) Table 58. Wuhan Institute of Biological Products Company Information Table 59. Wuhan Institute of Biological Products Business Overview Table 60. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 62. Wuhan Institute of Biological Products Recent Development Table 63. Serum China Company Information Table 64. Serum China Business Overview Table 65. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 67. Serum China Recent Development Table 68. Lanzhou Institute of Biological Products Company Information Table 69. Lanzhou Institute of Biological Products Business Overview Table 70. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 72. Lanzhou Institute of Biological Products Recent Development Table 73. Premium Serums Company Information Table 74. Premium Serums Business Overview Table 75. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 77. Premium Serums Recent Development Table 78. Haffkine Bio-Pharmaceutical Company Information Table 79. Haffkine Bio-Pharmaceutical Business Overview Table 80. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 82. Haffkine Bio-Pharmaceutical Recent Development Table 83. Bharat Serums Company Information Table 84. Bharat Serums Business Overview Table 85. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio Table 87. Bharat Serums Recent Development Table 88. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 91. North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 92. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 93. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 94. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 97. North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 98. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 99. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 100. North America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 104. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 105. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2027-2032) & (K Tons) Table 106. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 107. North America Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 108. United States Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 109. Canada Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 110. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 113. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 114. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 115. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 116. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 119. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 120. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 121. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 122. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 126. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 127. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2027-2032) & (K Tons) Table 128. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 129. Europe Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 130. Germany Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 131. France Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 132. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 133. Italy Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 135. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 136. China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 137. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 138. China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 139. China Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 140. China Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 141. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 142. China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 143. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 144. China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 145. China Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 146. China Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 147. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 150. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 151. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 152. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 153. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 156. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 157. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 158. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 159. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 163. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 164. Asia Equine Rabies Immunoglobulin (ERIG) Sales by Country (2027-2032) & (K Tons) Table 165. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 166. Asia Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 167. Japan Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 168. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 169. India Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 170. Australia Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2026) & (K Tons) Table 176. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Type (2027-2032) & (K Tons) Table 177. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2021-2026) & (US$/Ton) Table 178. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Type (2027-2032) & (US$/Ton) Table 179. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2026) & (K Tons) Table 182. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Application (2027-2032) & (K Tons) Table 183. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2021-2026) & (US$/Ton) Table 184. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Application (2027-2032) & (US$/Ton) Table 185. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 189. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2026) & (K Tons) Table 190. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Country (2027-2032) & (K Tons) Table 191. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2021-2026) & (US$/Ton) Table 192. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Price by Country (2027-2032) & (US$/Ton) Table 193. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 194. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 195. Chile Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 196. Colombia Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 197. Peru Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 199. Israel Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 200. UAE Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 201. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 202. Iran Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 203. Egypt Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Equine Rabies Immunoglobulin (ERIG) Distributors List Table 207. Equine Rabies Immunoglobulin (ERIG) Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Equine Rabies Immunoglobulin (ERIG) Image Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1500IU Image Figure 5. 1000IU Image Figure 6. 400IU Image Figure 7. Other Image Figure 8. Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Equine Rabies Immunoglobulin (ERIG) Market Size Share 2021 VS 2025 VS 2032 Figure 10. Category II Exposure Image Figure 11. Category III Exposure Image Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue (2021-2032) & (US$ Million) Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2021-2032) Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Sales (2021-2032) & (K Tons) Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Equine Rabies Immunoglobulin (ERIG) Sales YoY (2021-2032) & (K Tons) Figure 21. Europe Equine Rabies Immunoglobulin (ERIG) Sales YoY (2021-2032) & (K Tons) Figure 22. China Equine Rabies Immunoglobulin (ERIG) Sales YoY (2021-2032) & (K Tons) Figure 23. Asia (Excluding China) Equine Rabies Immunoglobulin (ERIG) Sales YoY (2021-2032) & (K Tons) Figure 24. South America, Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales YoY (2021-2032) & (K Tons) Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2021-2032) Figure 31. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2021-2032) Figure 34. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2021-2032) Figure 37. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 38. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2021-2032) Figure 40. North America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2021-2032) Figure 41. North America Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2021-2032) Figure 42. North America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2021-2032) Figure 43. North America Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2021-2032) Figure 44. North America Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2021-2032) Figure 45. North America Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2021-2032) Figure 46. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2021-2032) Figure 47. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2021-2032) Figure 48. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2021-2032) Figure 49. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2021-2032) Figure 50. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2021-2032) Figure 51. Europe Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2021-2032) Figure 52. China Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2021-2032) Figure 53. China Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2021-2032) Figure 54. China Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2021-2032) Figure 55. China Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2021-2032) Figure 56. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2021-2032) Figure 57. Asia Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2021-2032) Figure 58. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2021-2032) Figure 59. Asia Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2021-2032) Figure 60. Asia Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2021-2032) Figure 61. Asia Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2021-2032) Figure 62. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2021-2032) Figure 63. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2021-2032) Figure 64. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Share by Application (2021-2032) Figure 65. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Share by Application (2021-2032) Figure 66. SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Share by Country (2021-2032) Figure 67. SAMEA Equine Rabies Immunoglobulin (ERIG) Sales Share by Country (2021-2032) Figure 68. Equine Rabies Immunoglobulin (ERIG) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Equine Rabies Immunoglobulin (ERIG) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 1500IU
  • 1000IU
  • 400IU
  • Other
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Wuhan Institute of Biological Products
  • Serum China
  • Lanzhou Institute of Biological Products
  • Premium Serums
  • Haffkine Bio-Pharmaceutical
  • Bharat Serums

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Equine Rabies Immunoglobulin (ERIG) Market by Type
  3. 1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1500IU
  5. 1.2.3 1000IU
  6. 1.2.4 400IU
  7. 1.2.5 Other
  8. 1.3 Equine Rabies Immunoglobulin (ERIG) Market by Application
  9. 1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Category II Exposure
  11. 1.3.3 Category III Exposure
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Equine Rabies Immunoglobulin (ERIG) Market Dynamics
  1. 2.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
  2. 2.2 Equine Rabies Immunoglobulin (ERIG) Industry Drivers
  3. 2.3 Equine Rabies Immunoglobulin (ERIG) Industry Opportunities and Challenges
  4. 2.4 Equine Rabies Immunoglobulin (ERIG) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region
  3. 3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2021-2026)
  5. 3.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2027-2032)
  6. 3.2.4 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
  9. 3.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2021-2026)
  11. 3.4.3 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2027-2032)
  12. 3.4.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers
  2. 4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers
  6. 4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Equine Rabies Immunoglobulin (ERIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Equine Rabies Immunoglobulin (ERIG) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers, Product Type & Application
  13. 4.7 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Equine Rabies Immunoglobulin (ERIG) Market CR5 and HHI
  16. 4.8.2 2025 Equine Rabies Immunoglobulin (ERIG) Tier 1, Tier 2, and Tier 3
5 Equine Rabies Immunoglobulin (ERIG) Market by Type
  1. 5.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type
  2. 5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type
  6. 5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type
6 Equine Rabies Immunoglobulin (ERIG) Market by Application
  1. 6.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application
  2. 6.1.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application
  6. 6.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application
7 Company Profiles
  1. 7.1 Wuhan Institute of Biological Products
  2. 7.1.1 Wuhan Institute of Biological Products Company Information
  3. 7.1.2 Wuhan Institute of Biological Products Business Overview
  4. 7.1.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  6. 7.1.5 Wuhan Institute of Biological Products Recent Developments
  7. 7.2 Serum China
  8. 7.2.1 Serum China Company Information
  9. 7.2.2 Serum China Business Overview
  10. 7.2.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  12. 7.2.5 Serum China Recent Developments
  13. 7.3 Lanzhou Institute of Biological Products
  14. 7.3.1 Lanzhou Institute of Biological Products Company Information
  15. 7.3.2 Lanzhou Institute of Biological Products Business Overview
  16. 7.3.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  18. 7.3.5 Lanzhou Institute of Biological Products Recent Developments
  19. 7.4 Premium Serums
  20. 7.4.1 Premium Serums Company Information
  21. 7.4.2 Premium Serums Business Overview
  22. 7.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  24. 7.4.5 Premium Serums Recent Developments
  25. 7.5 Haffkine Bio-Pharmaceutical
  26. 7.5.1 Haffkine Bio-Pharmaceutical Company Information
  27. 7.5.2 Haffkine Bio-Pharmaceutical Business Overview
  28. 7.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  30. 7.5.5 Haffkine Bio-Pharmaceutical Recent Developments
  31. 7.6 Bharat Serums
  32. 7.6.1 Bharat Serums Company Information
  33. 7.6.2 Bharat Serums Business Overview
  34. 7.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
  36. 7.6.5 Bharat Serums Recent Developments
8 North America
  1. 8.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  2. 8.1.1 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
  3. 8.1.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
  4. 8.1.3 North America Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
  5. 8.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  6. 8.2.1 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
  7. 8.2.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
  8. 8.2.3 North America Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
  9. 8.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  10. 8.3.1 North America Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Equine Rabies Immunoglobulin (ERIG) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  2. 9.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
  4. 9.1.3 Europe Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
  5. 9.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  6. 9.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
  8. 9.2.3 Europe Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
  9. 9.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  10. 9.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Equine Rabies Immunoglobulin (ERIG) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  2. 10.1.1 China Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
  3. 10.1.2 China Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
  4. 10.1.3 China Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
  5. 10.2 China Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  6. 10.2.1 China Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
  7. 10.2.2 China Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
  8. 10.2.3 China Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  2. 11.1.1 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
  4. 11.1.3 Asia Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
  5. 11.2 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  6. 11.2.1 Asia Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
  8. 11.2.3 Asia Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
  9. 11.3 Asia Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  10. 11.3.1 Asia Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Equine Rabies Immunoglobulin (ERIG) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Equine Rabies Immunoglobulin (ERIG) Market Size by Type
  2. 12.1.1 SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
  5. 12.2 SAMEA Equine Rabies Immunoglobulin (ERIG) Market Size by Application
  6. 12.2.1 SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
  9. 12.3 SAMEA Equine Rabies Immunoglobulin (ERIG) Market Size by Country
  10. 12.3.1 SAMEA Equine Rabies Immunoglobulin (ERIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Equine Rabies Immunoglobulin (ERIG) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Equine Rabies Immunoglobulin (ERIG) Value Chain Analysis
  2. 13.1.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
  6. 13.2 Equine Rabies Immunoglobulin (ERIG) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Equine Rabies Immunoglobulin (ERIG) Distributors
  9. 13.2.3 Equine Rabies Immunoglobulin (ERIG) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst